FDA Drug Recalls

Recalls / Class II

Class IID-0279-2025

Product

Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04

Affected lot / code info
Lot # 109797, Exp 11/2026

Why it was recalled

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Recalling firm

Firm
Slate Run Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
277 W Nationwide Blvd Ste 260, N/A, Columbus, Ohio 43215-0169

Distribution

Quantity
2,444 bottles
Distribution pattern
Product was distributed to 8 distributors who may have further distribute the product nationwide.

Timeline

Recall initiated
2025-03-07
FDA classified
2025-03-17
Posted by FDA
2025-03-26
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0279-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.